Tianbo Jin
金天博，博士，教授，研究生导师，美国布朗大学医学博士后，中组部“西部之光”访问学者，陕西省基因组与健康学会副理事长兼秘书长。主要从事基于组学技术的复杂性疾病流行病学与分子机制研究、药物基因组群体遗传学研究、中药药效成分及分子药理学研究等。主持国家自然科学基金2项，国家博士后基金4项，省部级项目24项。发表SCI学术论文300余篇。省部级科学技术奖二等奖二项。 研究方向：复杂疾病分子机理研究、药物基因组学研究、群体遗传学研究 近五年主持与参与主要基金情况[1] 国家自然科学基金联合基金项目，U23A20476，高原移居人群脑习服的生理机制与干预策略，2024-01-01 至 2027-12-31，260万元，在研，参与[2] 国家自然科学基金，3... More>
Supervisor of Master's Candidates
E-Mail:
Date of Employment:2012-05-01
School/Department:生命科学学院
Education Level:With Certificate of Graduation for Doctorate Study
Gender:Male
Degree:Doctoral degree
Status:Employed
Alma Mater:西安交通大学
Discipline:Forensic Medicine
2002.9 - 2005.12
西安交通大学 | 法医学 | With Certificate of Graduation for Doctorate Study | Doctoral Degree in Medicine
1999.9 - 2002.6
西安交通大学 | 法医学 | With Certificate of Graduation for Study as Master's Candidates | Master's Degree in Medicine
1992.9 - 1997.6
西安医科大学 | 法医学 | University graduated | Bachelor's Degree in Medicine
- 马晓雅.The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.Cancer Chemother Pharmacol.2024,93 (5):481-496
- 张文静.Variants of KLF5 and KLF12 were related to endometrial cancer risk in the Chinese population.Expert Rev Mol Diagn.2024,24 (12):1181-1189
- 郭锦屏.Genetic Variability of CYP4F2, CYP2D6, CYP2E1, and ACE in the Chinese Yi Population.Biochem Genet.2024
- 杨乐腾.Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers. Oncology.Oncology.2024,102 (2):168-182
- 梁晶.CYP19A1 polymorphisms and bladder cancer risk in the Chinese Han population.Expert Rev Mol Diagn.2024,24 (8):743-752